SM
SMFNF
SUMITOMO MITSUI FINANCIAL GROUP, INC.
$38.49
-2.90%
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
Jun 1, 2026
SEC
SMFG disclosed the repurchase of 5,439,500 shares for JPY 32.4 billion (approx. US$230M) between May 14–31, 2026, under
6-K — Impact 3/10
May 29, 2026
SEC
Sumitomo Mitsui Financial Group filed a Form 6-K furnishing its Notice of Convocation of the 24th Ordinary General Meeti
6-K — Impact 2/10
May 13, 2026
SEC
SMFG disclosed a plan for its ESOP trust to acquire up to 1,094,000 of its own common shares (max cost JPY 6.564 billion
6-K — Impact 2/10
Analyst Ratings
3Strong Buy
14Buy
2Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 2.6/10.
NEUTRAL
6-K
3/10
SMFG disclosed the repurchase of 5,439,500 shares for JPY 32.4 billion (approx. US$230M) between May
Jun 1, 2026
NEUTRAL
6-K
2/10
Sumitomo Mitsui Financial Group filed a Form 6-K furnishing its Notice of Convocation of the 24th Or
May 29, 2026
NEUTRAL
6-K
2/10
SMFG disclosed a plan for its ESOP trust to acquire up to 1,094,000 of its own common shares (max co
May 13, 2026
NEUTRAL
6-K
3/10
SMFG announced a transition to an intermediate holding company structure for its securities business
May 12, 2026
NEUTRAL
6-K
3/10
Sumitomo Mitsui Financial Group announced a new long-term vision and a three-year management plan, i
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 89% buy across 19 analysts — 3 strong buy, 14 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1280.6B | 17.7% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1307.1B | 7.9% | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $5291.0B | 97.6% | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $5509.0B | 92.6% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 14 | 2 | 0 | 0 | 89% | |
| May 1, 2026 | 3 | 14 | 2 | 0 | 0 | 89% | |
| Apr 1, 2026 | 3 | 14 | 2 | 0 | 0 | 89% | |
| Mar 1, 2026 | 3 | 14 | 2 | 0 | 0 | 89% | |
| Feb 1, 2026 | 3 | 14 | 2 | 0 | 0 | 89% | |
| Jan 1, 2026 | 3 | 12 | 3 | 0 | 0 | 83% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.